New partnership will manage pathology workflows using a digital model

Omaha, Nebraska – The University of Nebraska Medical Center/Nebraska Medicine Department of Dermatology announced a partnership with PathologyWatch, a full-service pathology laboratory combining revolutionary digital technology with expert dermatopathology services to provide patients and doctors with an accurate and timely diagnosis. This new service aims to give Nebraska Medicine patients faster diagnoses and access to dermatopathologists anywhere.

“We are ecstatic at the med center to be partnered with PathologyWatch, experts in digital dermatopathology and artificial intelligence, to expand access to high-quality dermatopathology in our region,” said Ashley Wysong, MD, chair of the UNMC Department of Dermatology. “Specifically, dermatologists and primary care physicians will have access to our board-certified and fellowship-trained dermatopathologists at UNMC and PathologyWatch to improve patient care and diagnostic accuracy with quick specimen turnaround, digital images of skin biopsies integrated directly into electronic medical records, and opportunities to discuss challenging cases and clinicopathologic correlations with our dermatology-trained dermatopathologists. We are energized by this partnership with PathologyWatch and see many great things to come.”

Features and benefits of PathologyWatch include:

  • Patient biopsies are prepared on slides and digitized;
  • Dermatopathologists can read and interpret each specimen digitally ;
  • Detailed reports are delivered electronically; and
  • Dermatologists have quick access to communicate with dermatopathologists on interpretations.

Corey Georgesen, MD, assistant professor and director of dermatopathology at UNMC, will be the dermatopathologist entering the program. Dr. Georgesen is a board-certified and fellowship trained dermatologist, dermatopathologist and telemedicine specialist with Nebraska roots and diverse training experience. He will be working in collaboration with April Larson, MD, chief medical officer of PathologyWatch.

“This collaboration will foster forward-thinking and innovative diagnostic techniques for patients in the Nebraska and Midwest community,” Dr. Georgesen said. “Working together, we will utilize technological advances to analyze skin biopsies. Our symbiosis undoubtedly will translate into a model that will become a beacon for excellent and effective patient care. The future is bright.”

“We are very excited about this partnership,” Dr. Larson said. “Our goal to make life-saving diagnostic technology accessible and affordable is advanced in a meaningful way with our affiliation with the UNMC team. We are proud to partner with this state-of-the-art organization and look forward to providing these important services in the Nebraska area.”

For more information about PathologyWatch, visit pathologywatch.com or email. For media inquiries, contact Amy Cook at 949-813-0182 or via email.

To schedule a demo, contact Aaron Christensen via email.

                                                                                                            ###

About UNMC and Nebraska Medicine

We are Nebraska Medicine and UNMC. Our mission is to lead the world in transforming lives to create a healthy future for all individuals and communities through premier educational programs, innovative research and extraordinary patient care.

About PathologyWatch

PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the PathologyWatch expert professional team and laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision-making to deliver unprecedented patient care.